Global Glycan Analysis and Glycopeptide Analysis 麻豆原创 Research Report 2025

Publication ID:

PB502255858

Publication Date:

February 10, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

The global market for Glycan Analysis and Glycopeptide Analysis was valued at US$ 394 million in the year 2024 and is projected to reach a revised size of US$ 535 million by 2031, growing at a CAGR of 4.6% during the forecast period.
Glycan analysis and glycopeptide analysis refer to the process of qualitatively and quantitatively studying glycosylation modifications on proteins using a variety of biochemical and mass spectrometry techniques. These analytical methods are of great significance for understanding cell biology, disease mechanisms, and the development of new therapeutic methods.
North American market for Glycan Analysis and Glycopeptide Analysis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Glycan Analysis and Glycopeptide Analysis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Glycan Analysis and Glycopeptide Analysis in Scientific Research is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Glycan Analysis and Glycopeptide Analysis include Thermo Fisher, Creative Proteomics, Bioinformatics Solutions Inc., Bruker, NIBSC, Waters, Ludger, Rapid Novor, FyonBio, Prolytix, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Glycan Analysis and Glycopeptide Analysis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glycan Analysis and Glycopeptide Analysis.
The Glycan Analysis and Glycopeptide Analysis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Glycan Analysis and Glycopeptide Analysis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glycan Analysis and Glycopeptide Analysis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Thermo Fisher
Creative Proteomics
Bioinformatics Solutions Inc.
Bruker
NIBSC
Waters
Ludger
Rapid Novor
FyonBio
Prolytix
Agilent
Asparia Glycomics
Segment by Type
Glycan Analysis
Glycopeptide Analysis
Segment by Application
Scientific Research
Medical Diagnosis
Drug Development
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Glycan Analysis and Glycopeptide Analysis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Glycan Analysis and Glycopeptide Analysis 麻豆原创 Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Glycan Analysis
1.2.3 Glycopeptide Analysis
1.3 麻豆原创 by Application
1.3.1 Global Glycan Analysis and Glycopeptide Analysis 麻豆原创 Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Scientific Research
1.3.3 Medical Diagnosis
1.3.4 Drug Development
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Glycan Analysis and Glycopeptide Analysis 麻豆原创 Perspective (2020-2031)
2.2 Global Glycan Analysis and Glycopeptide Analysis Growth Trends by Region
2.2.1 Global Glycan Analysis and Glycopeptide Analysis 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
2.2.2 Glycan Analysis and Glycopeptide Analysis Historic 麻豆原创 Size by Region (2020-2025)
2.2.3 Glycan Analysis and Glycopeptide Analysis Forecasted 麻豆原创 Size by Region (2026-2031)
2.3 Glycan Analysis and Glycopeptide Analysis 麻豆原创 Dynamics
2.3.1 Glycan Analysis and Glycopeptide Analysis Industry Trends
2.3.2 Glycan Analysis and Glycopeptide Analysis 麻豆原创 Drivers
2.3.3 Glycan Analysis and Glycopeptide Analysis 麻豆原创 Challenges
2.3.4 Glycan Analysis and Glycopeptide Analysis 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Glycan Analysis and Glycopeptide Analysis Players by Revenue
3.1.1 Global Top Glycan Analysis and Glycopeptide Analysis Players by Revenue (2020-2025)
3.1.2 Global Glycan Analysis and Glycopeptide Analysis Revenue 麻豆原创 Share by Players (2020-2025)
3.2 Global Top Glycan Analysis and Glycopeptide Analysis Players by Company Type and 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Glycan Analysis and Glycopeptide Analysis Revenue
3.4 Global Glycan Analysis and Glycopeptide Analysis 麻豆原创 Concentration Ratio
3.4.1 Global Glycan Analysis and Glycopeptide Analysis 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Glycan Analysis and Glycopeptide Analysis Revenue in 2024
3.5 Global Key Players of Glycan Analysis and Glycopeptide Analysis Head office and Area Served
3.6 Global Key Players of Glycan Analysis and Glycopeptide Analysis, Product and Application
3.7 Global Key Players of Glycan Analysis and Glycopeptide Analysis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Glycan Analysis and Glycopeptide Analysis Breakdown Data by Type
4.1 Global Glycan Analysis and Glycopeptide Analysis Historic 麻豆原创 Size by Type (2020-2025)
4.2 Global Glycan Analysis and Glycopeptide Analysis Forecasted 麻豆原创 Size by Type (2026-2031)
5 Glycan Analysis and Glycopeptide Analysis Breakdown Data by Application
5.1 Global Glycan Analysis and Glycopeptide Analysis Historic 麻豆原创 Size by Application (2020-2025)
5.2 Global Glycan Analysis and Glycopeptide Analysis Forecasted 麻豆原创 Size by Application (2026-2031)
6 North America
6.1 North America Glycan Analysis and Glycopeptide Analysis 麻豆原创 Size (2020-2031)
6.2 North America Glycan Analysis and Glycopeptide Analysis 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Glycan Analysis and Glycopeptide Analysis 麻豆原创 Size by Country (2020-2025)
6.4 North America Glycan Analysis and Glycopeptide Analysis 麻豆原创 Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Glycan Analysis and Glycopeptide Analysis 麻豆原创 Size (2020-2031)
7.2 Europe Glycan Analysis and Glycopeptide Analysis 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Glycan Analysis and Glycopeptide Analysis 麻豆原创 Size by Country (2020-2025)
7.4 Europe Glycan Analysis and Glycopeptide Analysis 麻豆原创 Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Glycan Analysis and Glycopeptide Analysis 麻豆原创 Size (2020-2031)
8.2 Asia-Pacific Glycan Analysis and Glycopeptide Analysis 麻豆原创 Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Glycan Analysis and Glycopeptide Analysis 麻豆原创 Size by Region (2020-2025)
8.4 Asia-Pacific Glycan Analysis and Glycopeptide Analysis 麻豆原创 Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Glycan Analysis and Glycopeptide Analysis 麻豆原创 Size (2020-2031)
9.2 Latin America Glycan Analysis and Glycopeptide Analysis 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Glycan Analysis and Glycopeptide Analysis 麻豆原创 Size by Country (2020-2025)
9.4 Latin America Glycan Analysis and Glycopeptide Analysis 麻豆原创 Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Glycan Analysis and Glycopeptide Analysis 麻豆原创 Size (2020-2031)
10.2 Middle East & Africa Glycan Analysis and Glycopeptide Analysis 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Glycan Analysis and Glycopeptide Analysis 麻豆原创 Size by Country (2020-2025)
10.4 Middle East & Africa Glycan Analysis and Glycopeptide Analysis 麻豆原创 Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Details
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher Glycan Analysis and Glycopeptide Analysis Introduction
11.1.4 Thermo Fisher Revenue in Glycan Analysis and Glycopeptide Analysis Business (2020-2025)
11.1.5 Thermo Fisher Recent Development
11.2 Creative Proteomics
11.2.1 Creative Proteomics Company Details
11.2.2 Creative Proteomics Business Overview
11.2.3 Creative Proteomics Glycan Analysis and Glycopeptide Analysis Introduction
11.2.4 Creative Proteomics Revenue in Glycan Analysis and Glycopeptide Analysis Business (2020-2025)
11.2.5 Creative Proteomics Recent Development
11.3 Bioinformatics Solutions Inc.
11.3.1 Bioinformatics Solutions Inc. Company Details
11.3.2 Bioinformatics Solutions Inc. Business Overview
11.3.3 Bioinformatics Solutions Inc. Glycan Analysis and Glycopeptide Analysis Introduction
11.3.4 Bioinformatics Solutions Inc. Revenue in Glycan Analysis and Glycopeptide Analysis Business (2020-2025)
11.3.5 Bioinformatics Solutions Inc. Recent Development
11.4 Bruker
11.4.1 Bruker Company Details
11.4.2 Bruker Business Overview
11.4.3 Bruker Glycan Analysis and Glycopeptide Analysis Introduction
11.4.4 Bruker Revenue in Glycan Analysis and Glycopeptide Analysis Business (2020-2025)
11.4.5 Bruker Recent Development
11.5 NIBSC
11.5.1 NIBSC Company Details
11.5.2 NIBSC Business Overview
11.5.3 NIBSC Glycan Analysis and Glycopeptide Analysis Introduction
11.5.4 NIBSC Revenue in Glycan Analysis and Glycopeptide Analysis Business (2020-2025)
11.5.5 NIBSC Recent Development
11.6 Waters
11.6.1 Waters Company Details
11.6.2 Waters Business Overview
11.6.3 Waters Glycan Analysis and Glycopeptide Analysis Introduction
11.6.4 Waters Revenue in Glycan Analysis and Glycopeptide Analysis Business (2020-2025)
11.6.5 Waters Recent Development
11.7 Ludger
11.7.1 Ludger Company Details
11.7.2 Ludger Business Overview
11.7.3 Ludger Glycan Analysis and Glycopeptide Analysis Introduction
11.7.4 Ludger Revenue in Glycan Analysis and Glycopeptide Analysis Business (2020-2025)
11.7.5 Ludger Recent Development
11.8 Rapid Novor
11.8.1 Rapid Novor Company Details
11.8.2 Rapid Novor Business Overview
11.8.3 Rapid Novor Glycan Analysis and Glycopeptide Analysis Introduction
11.8.4 Rapid Novor Revenue in Glycan Analysis and Glycopeptide Analysis Business (2020-2025)
11.8.5 Rapid Novor Recent Development
11.9 FyonBio
11.9.1 FyonBio Company Details
11.9.2 FyonBio Business Overview
11.9.3 FyonBio Glycan Analysis and Glycopeptide Analysis Introduction
11.9.4 FyonBio Revenue in Glycan Analysis and Glycopeptide Analysis Business (2020-2025)
11.9.5 FyonBio Recent Development
11.10 Prolytix
11.10.1 Prolytix Company Details
11.10.2 Prolytix Business Overview
11.10.3 Prolytix Glycan Analysis and Glycopeptide Analysis Introduction
11.10.4 Prolytix Revenue in Glycan Analysis and Glycopeptide Analysis Business (2020-2025)
11.10.5 Prolytix Recent Development
11.11 Agilent
11.11.1 Agilent Company Details
11.11.2 Agilent Business Overview
11.11.3 Agilent Glycan Analysis and Glycopeptide Analysis Introduction
11.11.4 Agilent Revenue in Glycan Analysis and Glycopeptide Analysis Business (2020-2025)
11.11.5 Agilent Recent Development
11.12 Asparia Glycomics
11.12.1 Asparia Glycomics Company Details
11.12.2 Asparia Glycomics Business Overview
11.12.3 Asparia Glycomics Glycan Analysis and Glycopeptide Analysis Introduction
11.12.4 Asparia Glycomics Revenue in Glycan Analysis and Glycopeptide Analysis Business (2020-2025)
11.12.5 Asparia Glycomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Thermo Fisher
Creative Proteomics
Bioinformatics Solutions Inc.
Bruker
NIBSC
Waters
Ludger
Rapid Novor
FyonBio
Prolytix
Agilent
Asparia Glycomics

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.